Oncozenge AB (ONCOZ) — Financial Flexibility Index
Oncozenge AB (ONCOZ) has a Financial Flexibility Index of 0.37x as of December 2025. Free cash flow of Skr5.82 Million (operating CF Skr-7.24 Million minus capex Skr13.06 Million) represents 0% of total liabilities (Skr15.92 Million). Also explore net asset momentum of Oncozenge AB to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncozenge AB Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Oncozenge AB across 6 annual periods. See Oncozenge AB balance sheet independence to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Oncozenge AB (2020–2025)
Year-by-year free cash flow to debt coverage for Oncozenge AB. For the full company profile including market capitalisation, see Oncozenge AB stock valuation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-13.06 Million | Skr15.92 Million | ▲ +100.0% |
| 2024 | -5.91x | Skr-8.76 Million | Skr-8.76 Million | Skr1.48 Million | ▲ +41.3% |
| 2023 | -10.05x | Skr-17.08 Million | Skr-17.08 Million | Skr1.70 Million | ▼ -33.0% |
| 2022 | -7.56x | Skr-22.08 Million | Skr-22.08 Million | Skr2.92 Million | ▼ -6395.2% |
| 2021 | 0.12x | Skr589.00K | Skr-4.77 Million | Skr4.90 Million | ▲ +108363.6% |
| 2020 | 0.00x | Skr-1.00K | Skr-1.00K | Skr9.01 Million | — |